Remdesivir procured at high prices to save lives: BMC

BJP alleges corruption, but Mumbai authorities say Haffkine tender had no response

geetanjali

Geetanjali Minhas | April 16, 2021 | Mumbai


#Maharashtra   #Mumbai   #BMC   #healthcare   #Remdesivir   #Covid-19  


Countering the opposition BJP’s allegations of corruption in the procurement of Remdesivir, a critical anti-viral injection often prescribed for Covid-19 patients, the BrihanMumbai municipal corporation (BMC) has clarified that its decision to procure the drug was aimed at saving  lives even if it meant spending some extra money to procure it.

Remdesivir, said to be a life-saving drug for some serious patients, is in high demand in Maharashtra, which has been registering upwards of 50,000 new cases every day for some time. It is also in short supply, with reports of astronomical prices in the black market.

The BMC has procured Remdesivir at Rs 1568 per vial as against the state-owned Haffkine Institute’s order price of Rs 565 and the wholesale price of Rs 1200. That promoted BJP to demand a probe by the Anti-Corruption Bureau. But the civic authorities have refuted the allegations as incorrect.

The BMC has said that after Haffkine Bio-Pharmaceutical Corporation placed an order to procure 57,100 vials of Remdesivir at the rate of Rs 665 on April 1, 2021 and received no supply, BMC on April 5 floated  a tender for purchase of 2,00,000 vials of Remdesivir which was due on April 7.

A single bid was received from Mylan Laboratories on April 7 at 4.00 pm with the price of Rs 1,568 inclusive of GST per each vial. At that time BMC had stocks of 10,471 vials which would last for barely three-four days. That day BMC had approached Cipla for supplies of around 10,000 vials and Cipla had expressed its inability to commit supply of any vial immediately.

Given the high demand, Mylan refused to reduce its bid price. With more than 17,431 beds under the BMC occupied by Covid patients on April 7, it went ahead and placed an order to procure 2,00,000  vials of Remdesivir out of which 25,000 vials were received immediately.

[BJP meanwhile has cited a letter dated April 9 from Haffkine to Cadilla Healthcare confirming its bid for 57,100 vials at Rs 665.84 each for a total price of Rs 3,80,19,464.]

As per BMC, the Haffkine order of 57,100 vials at the rate of Rs.665 has not elicited any response so far and no supplies have been made. It also said that a false perception has been created that Remdesivir has been procured at very high rates.

“It was imperative to act fast and decisively to procure Remdesivir on 7th April 2021 or MCGM would have faced a huge crisis to treat patients. Any delay would have resulted in Remdesivir going out to other cities and states of India, bringing a bad name to MCGM especially when Mumbai is the financial capital of India. Between money and human lives, MCGM opted to save all possible human lives even if it meant spending extra amount of money for securing 2,00,000 vials of Remdesivir,” said municipal commissioner Iqbal Singh Chahal.

The BMC also points out that on April 14, the Pune divisional commissioner had requested it (BMC) to spare 20,000 vials of Remdesivir at its purchase price of Rs 1568 per vial, saying that Mylan had declined to supply due to prior commitments and lack of stocks.

Also, the BMC has pointed out that Mylan has received orders from several authorities including the Surat municipal corporation, the Satara district hospital, the commissioner of medical education in Madhya Pradesh, the NHM mission director in Assam, Navi Mumbai Municipal Corporation and Gujarat Medical Services Corporation.

Comments

 

Other News

Making sense of facts – and alternative facts

The Art of Conjuring Alternate Realities: How Information Warfare Shapes Your World By Shivam Shankar Singh and Anand Venkatanarayanan HarperCollins / 284 pages / Rs 599 Professor Noam Chomsky, linguist and public intellectual, has often spoken of &ls

The Manali Trance: Economics of Abandoning Caution in the Time of Coronavirus

The brutal second wave of the COVID-19 pandemic in India has left a significant death toll in its wake. Health experts advise that the imminent third wave can be delayed by following simple measures like wearing a mask and engaging in social distancing. However, near the end of the second wave, we witnesse

Govt considers fixing driving hrs of commercial vehicles

Union Minister of Road Transport and Highways Nitin Gadkari has emphasised deciding driving hours for truck drivers of commercial vehicles, similar to pilots, to reduce fatigue-induced road accidents. In a Na

Telecom department simplifies KYC processes for mobile users

In a step towards Telecom Reforms which aim to provide internet and tele connectivity for the marginalised section, the Department of Telecommunications, Ministry of Communica

Mumbai think tank calls for climate action

Raising concerns over rising seawater levels and climate change, Mumbai First, a 25-year-old public-private partnership policy think tank, has written letters to Maharashtra chief minister Uddhav Thackeray, minister for environment and climate change, tourism and protocol, Aditya Thackeray and Mumbai munic

Creation of ‘good bank’ as important as ‘bad bank’ for NPA management

After the recent announcement of the government guarantee for Security Receipts (SRs) to be issued by a public sector-owned National Asset Reconstruction Company Ltd (NARCL), there is a surge of interest around this desi version of a super bad bank. The entity will acquire around ₹2 trillion bad debts fr

Visionary Talk: Gurcharan Das, Author, Commentator & Public Intellectual on key governance issues


Archives

Current Issue

Opinion

Facebook    Twitter    Google Plus    Linkedin    Subscribe Newsletter

Twitter